Newsroom

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Lonza and CN Bio announce distribution agreement providing prevalidated hepatocytes for use on innovative organ-on-a-chip range

July 19, 2021

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Five Arrows invests in Sygnature Discovery

June 29, 2021

Categories: Drug Discovery & Development, Clinical Research & Trials

The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial

June 28, 2021

Categories: Drug Discovery & Development, Clinical Research & Trials

Sygnature Discovery expands into early CMC development

June 18, 2021

Categories: Biotechnology, Drug Discovery & Development

3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery

June 8, 2021

Categories: Biotechnology, Drug Discovery & Development, Clinical Research & Trials

COREX Logistics opens Kazakhstan office

June 1, 2021

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Sygnature Discovery appoints Dr. David Lustig to spearhead US expansion

May 6, 2021

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Sygnature Discovery expands US presence with office in Bay Area biotech hub

April 27, 2021

Categories: Computing & Technology, Drug Discovery & Development

ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development

March 30, 2021